A Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate Cancer
Clinical trial NCT06010914 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06010914
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-09
- Primary completion
- 2026-03-16
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.